By Healthcare and Life Sciences Practice Leaders | August 07, 2018

Telemedicine Expansion Warrants Greater Controls to Ensure HIPAA Compliance

As telemedicine reaches its tipping point, healthcare organizations need to apply adequate security controls to enable HIPAA compliance. We outline the NIST SP 800-66 r1 and NIST 800-53 r4 publications, which contain a comprehensive set of controls that healthcare entities can...


By Healthcare and Life Sciences Practice Leaders | July 11, 2018

Why More Seniors Will Start Spending Their Final Days at Home

In response to the growth of the aging population, healthcare providers are planning to focus near-term investment in home health care and models that support it. For these innovative models to be successful, patients and their providers will need to speak openly about what...


By Healthcare and Life Sciences Practice Leaders | July 10, 2018

Podcast: Money-based Guarantee – The Next Drug Pricing Model?

In the fourth episode of BDO’s Healthcare Rx Podcast, BDO’s Dr. David Friend talks about developing models and measurements for value-based care as a method to lower drug prices. Joining him are Ann Kraft, executive director of Purdue Pharma; and Dr. Steven Small, professor of...


By Healthcare and Life Sciences Practice Leaders | July 03, 2018

Elder Care Independence: Where Provider & Investor Outlooks Align

If you want to understand the future of elder care, follow the money. Our latest blog analyzes recent CBRE survey and deal-making data to understand where investors are placing their bets.


By Healthcare and Life Sciences Practice Leaders | June 28, 2018

Negative Side Effects of Tax Reform for Life Sciences

The tax benefits of orphan drugs, R&D expenses and employee fringe benefits lose weight under the new tax law. How will tax implications impact your organizational strategies?


By Healthcare and Life Sciences Practice Leaders | June 21, 2018

Maximizing Data Integrity to Mitigate Government Pricing Risk

In an era of pricing transparency and increasing calls for even greater government pricing regulation, government pricing risk is heightened for drug manufacturers. Ensuring data integrity is key. Discover ways to monitor and review third-party vendor data and identify areas...


By Healthcare and Life Sciences Practice Leaders | June 14, 2018

Finding the Right Dose of Portfolio Risk

In the third episode of BDO’s Healthcare Rx Podcast, Steven Shill, partner and national leader of The BDO Center for Healthcare Excellence & Innovation, talks with Dr. Christopher Kersey, founding partner of Havencrest Healthcare Partners; Bert Notini, managing director with...


By Karen Meador | June 12, 2018

How Medical Necessity Disputes Cause Hospitals to Leave Revenue on the Table

In a time of heightened financial pressure on providers, medical necessity disputes are causing them to leave revenue on the table. Proper documentation before litigation is key to reducing the frequency of care ending up in dispute.


By Healthcare and Life Sciences Practice Leaders | May 25, 2018

Are You Leveraging the R&D Tax Credit to Help Fund Healthcare Transformation?

As healthcare transforms, investment in tech and IT improvements is no longer an option. A surprising number of organizations are missing critical opportunities to offset the cost of innovation by leveraging the R&D tax credit.


By Healthcare and Life Sciences Practice Leaders | May 08, 2018

Vlog: Why Data is Healthcare’s Most Valuable Resource

What ‘secret sauce’ is driving disruptive mergers in healthcare? For starters: data. Our latest blog explains why—and features BDO’s Dr. David Friend offering his take on one of the most recent data-driven deals with CNBC.